406 E2- Parkinson's Pharm Flashcards

1
Q

what is the treatment goal of parkinson’s

A

help individuals maintain their motor function for as long as possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

when is treatment for parkinson’s started

A

if symptoms affect dominate hand or if symptoms interfere w/ work, ADLs, social or leisure function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

dopaminergic drugs can either

A

increase the amount of dopamine or increase the stimulation of dopamine receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what do anticholinergic drugs do

A

block the effects of ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

sinemet (combo of levodopa & carbidopa) : MOA

A

-levodopa: converts to dopamine in the brain and activates dopamine receptors
-carbidopa: blocks destruction of levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the most effective drug for PD

A

sinemet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

disadvantages to sinemet

A

-takes several months to see improvement
-does not work long term
-adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

sinemet: “loss of effect”

A

-dose wears off so may need shorter dose intervals
-“on off” phenomenon: the abrupt loss of effect that can occur anytime during dosing interval
off periods increase overtime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what can reduce the effect of sinemet

A

-other drugs
-high protein meals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

sinemet: adverse effects

A

-N/v
-Dyskinesias (abnormal movements)
-postural hypotension
-dysrhythmias
-psychosis (hallucinations, nightmares, paranoia)
-darken sweat & urine
-activate malignant melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

sinemet nursing considerations

A

-give low doses w/ food (not protein rich food)
-monitor cardiac function (esp if dose is being increases)
-tell pts to change positions slowly
-skin assessment before giving

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

sinemet interactions causing a decreased effect of levodopa

A

-vit B6 (pyridoxine)
-antipsychotics
-protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

sinemet interactions causes a increased effect of levodopa

A

-carbidopa
-anticholinergics
-MAO inhibitors (can cause toxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

sinemet: route

A

PO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

duopa

A

carbidopa-levodopa infusion for G or J tube
-gel form suspension
-continuous (up to 16 hrs/d) infusion for continuous blood level
keeps a more consistent amount of the drug in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when is duopa used

A

-when a patient has a tube
-for pts who do not respond well to sinemet
-pts w/ on off phen

17
Q

duopa teaching

A

-do not take within 2 weeks of nonselective MAOI
-talk about all medications pt is currently taking

18
Q

duopa: drug interactions

A

-anti HTN
-MAOI
-antipsychotic
-metoclopramide
-isoniazid
-iron
-vitamins

19
Q

duopa: food interactions

A

high protein

20
Q

duopa side effects

A

-falling asleep w/o warning
-orthostatic hypotension
-hallucinations
-unusual urges
-depression
-dyskinesia
side effects also include those related to placement of tube

21
Q

side effects of tube placement

A

-infection
-tube dislodgment
-body disturbances

22
Q

what class is pramipexole

A

dopamine receptor agonist

23
Q

pramipexole: MOA

A

binds w/ D2 receptors

24
Q

pramipexole: indications

A

-monotherapy in early PD
-combined w/ sinemet in advanced PD
-restless leg syndrome

25
Q

pramipexole SE (alone)

A

-nausea
-sleep attacks
-pathologic gambling & other compulsive behaviors

26
Q

pramipexole SE (paired w/ levodopa)

A

-orthostatic hypotension
-dyskinesias
-hallucination risk double

27
Q

what class is ropinirole

A

dopamine receptor agonist

28
Q

ropinirole MOA

A

stimulates dopamine receptor
exact moa is not known but could increase nerve impulses within the substantia nigra

29
Q

ropinirole indications

A

idiopathic PD

30
Q

ropinirole SE

A

-similar to other PD drug
-long term use there may be an increased risk of DM and acromegaly

31
Q

rotigotine

A

-dopamine receptor agonist
-once daily patch

32
Q

apomorphine

A

-dopamine receptor agonist
-short acting subq injection
-for fast relief of symptoms
used in the “off” phase of PD